Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

Though there are multiple possible reasons that people may discontinue treatment with GLP-1 receptor agonists, high ...

Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...

Provides longer GLP-1 receptor activation. Depending on the medication, the effects can last for a minimum of 24 hours to a ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...